Meet Some of the Physicians
and Cervical Spinal Cord
Injury Patients in the
AST-OPC1 Clinical Trial
 

SEC Filings



Date Filed Type Description Filer View
November 07, 20133Initial filing by director officer or owner of more than ten percent.NORDHOFF HENRY L
November 01, 20138-KReport of unscheduled material events or corporate event 
October 28, 20138-KReport of unscheduled material events or corporate event 
October 11, 20138-KReport of unscheduled material events or corporate event 
October 09, 20133Initial filing by director officer or owner of more than ten percent.GERON CORP
October 09, 2013SC 13DFiling by person(s) reporting owned shares of common stock in a public company >5% 
October 09, 2013SC 13DFiling by person(s) reporting owned shares of common stock in a public company >5% 
October 09, 2013SC 13DFiling by person(s) reporting owned shares of common stock in a public company >5% 
October 02, 20134Statement of changes in beneficial ownership of securitiesBIOTIME INC
October 01, 20138-KReport of unscheduled material events or corporate event 
September 30, 20133Initial filing by director officer or owner of more than ten percent.KINGSLEY ALFRED D
September 27, 2013EFFECTEFFECT 
September 27, 20133Initial filing by director officer or owner of more than ten percent.Peabody Robert
September 27, 20133Initial filing by director officer or owner of more than ten percent.OKARMA THOMAS
September 27, 20133Initial filing by director officer or owner of more than ten percent.LEBKOWSKI JANE
September 27, 20133Initial filing by director officer or owner of more than ten percent.SPINK KATHARINE E.
September 27, 20133Initial filing by director officer or owner of more than ten percent.VON ESCHENBACH
September 27, 20133Initial filing by director officer or owner of more than ten percent.BERGER FRANKLIN M
September 27, 20133Initial filing by director officer or owner of more than ten percent.WEST MICHAEL D
September 27, 20133Initial filing by director officer or owner of more than ten percent.BIOTIME INC
<< first | prev | next | last >>
page (13 of 14)
Asterias Biotherapeutics Tel: (510) 456-3800